Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PBH
PBH logo

PBH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Prestige Consumer Healthcare Inc (PBH) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast PBH stock price to rise
4 Analyst Rating
Wall Street analysts forecast PBH stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 48.020
sliders
Low
66
Averages
76
High
86
Current: 48.020
sliders
Low
66
Averages
76
High
86
Canaccord
Buy
to
Buy
downgrade
$86 -> $72
AI Analysis
2026-05-15
Reason
Canaccord
Price Target
$86 -> $72
AI Analysis
2026-05-15
downgrade
Buy
to
Buy
Reason
Canaccord lowered the firm's price target on Prestige Consumer to $72 from $86 and keeps a Buy rating on the shares. The firm updated its model following its Q4 miss which was driven primarily by continued eye care weakness coupled with incremental pressure from the Iran conflict.
Oppenheimer
Rupesh Parikh
Outperform
to
Perform
downgrade
2026-05-14
Reason
Oppenheimer
Rupesh Parikh
Price Target
2026-05-14
downgrade
Outperform
to
Perform
Reason
As previously reported, Oppenheimer analyst Rupesh Parikh downgraded Prestige Consumer to Perform from Outperform following the company's softer than expected Q4 results and weaker initial FY26 guidance. Oppenheimer expected a below consensus guide, but this was worse than it envisioned. With management now digesting two acquisitions, higher leverage, and a more uncertain consumer backdrop, the firm sees a weaker outperformance case.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PBH
Unlock Now

People Also Watch